These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 22297848)

  • 1. Parainflammation, chronic inflammation, and age-related macular degeneration.
    Chen M; Xu H
    J Leukoc Biol; 2015 Nov; 98(5):713-25. PubMed ID: 26292978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microglia in Retinal Degeneration.
    Rashid K; Akhtar-Schaefer I; Langmann T
    Front Immunol; 2019; 10():1975. PubMed ID: 31481963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population genetic tools for dissecting innate immunity in humans.
    Quintana-Murci L; Clark AG
    Nat Rev Immunol; 2013 Apr; 13(4):280-93. PubMed ID: 23470320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate immunity activation on biomaterial surfaces: a mechanistic model and coping strategies.
    Ekdahl KN; Lambris JD; Elwing H; Ricklin D; Nilsson PH; Teramura Y; Nicholls IA; Nilsson B
    Adv Drug Deliv Rev; 2011 Sep; 63(12):1042-50. PubMed ID: 21771620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal pigment epithelium and microglia express the CD5 antigen-like protein, a novel autoantigen in age-related macular degeneration.
    Iannaccone A; Hollingsworth TJ; Koirala D; New DD; Lenchik NI; Beranova-Giorgianni S; Gerling IC; Radic MZ; Giorgianni F
    Exp Eye Res; 2017 Feb; 155():64-74. PubMed ID: 27989757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microglia in the healthy and degenerating retina: insights from novel mouse models.
    Karlstetter M; Ebert S; Langmann T
    Immunobiology; 2010; 215(9-10):685-91. PubMed ID: 20573418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classical complement activation and acquired immune response pathways are not essential for retinal degeneration in the rd1 mouse.
    Rohrer B; Demos C; Frigg R; Grimm C
    Exp Eye Res; 2007 Jan; 84(1):82-91. PubMed ID: 17069800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal microglia: just bystander or target for therapy?
    Karlstetter M; Scholz R; Rutar M; Wong WT; Provis JM; Langmann T
    Prog Retin Eye Res; 2015 Mar; 45():30-57. PubMed ID: 25476242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between Neisseria meningitidis and the complement system.
    Schneider MC; Exley RM; Ram S; Sim RB; Tang CM
    Trends Microbiol; 2007 May; 15(5):233-40. PubMed ID: 17398100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immune mechanisms in retinal degeneration].
    Karlstetter M; Langmann T
    Klin Monbl Augenheilkd; 2012 Mar; 229(3):221-6. PubMed ID: 22297848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microglia activation in retinal degeneration.
    Langmann T
    J Leukoc Biol; 2007 Jun; 81(6):1345-51. PubMed ID: 17405851
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.